Iran - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran - 2022
Contents:
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (CIF) - 2022
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (FOB) - 2022
- Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran
- Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (CIF) - 2022
The average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $68,995 per ton in 2022, increasing by 11% against the previous year. In general, the import price recorded a strong expansion. The growth pace was the most rapid in 2015 when the average import price increased by 87%. As a result, import price attained the peak level of $131,976 per ton. From 2016 to 2022, the average import prices remained at a somewhat lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was France ($243,749 per ton), while the price for India ($13,080 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+11.0%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (FOB) - 2022
The average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $9,922 per ton in 2022, dropping by -38.7% against the previous year. Overall, the export price continues to indicate a abrupt decrease. The pace of growth was the most pronounced in 2021 an increase of 88% against the previous year. Over the period under review, the average export prices reached the peak figure at $35,510 per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.
There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Azerbaijan ($22,080 per ton), while the average price for exports to Tajikistan ($2,996 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Azerbaijan (+24.7%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran
In 2022, the amount of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses imported into Iran soared to 648 tons, growing by 230% against the year before. Over the period under review, imports continue to indicate significant growth. The growth pace was the most rapid in 2020 with an increase of 1,107% against the previous year. As a result, imports reached the peak of 1.3K tons. From 2021 to 2022, the growth of imports of remained at a somewhat lower figure.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses soared to $45M in 2022. Overall, imports saw a significant increase. The pace of growth appeared the most rapid in 2020 with an increase of 1,781%. As a result, imports reached the peak of $77M. From 2021 to 2022, the growth of imports of remained at a somewhat lower figure.
| Import of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| France | 0.9 | 21.8 | 3.1 | 9.9 | 122.4% |
| Slovenia | 0.5 | 8.8 | 2.4 | 8.9 | 161.1% |
| Austria | N/A | 2.4 | 0.2 | 1.5 | -20.9% |
| China | 0.5 | 3.6 | N/A | 0.9 | 21.6% |
| India | 0.3 | 5.0 | 0.1 | 0.8 | 38.7% |
| Others | 1.9 | 35.5 | 6.3 | 22.7 | 128.6% |
| Total | 4.1 | 77.2 | 12.2 | 44.7 | 121.7% |
Top Suppliers of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses to Iran in 2022:
- Slovenia (98.1 tons)
- Austria (87.7 tons)
- India (59.8 tons)
- China (42.2 tons)
- France (40.8 tons)
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran
In 2022, overseas shipments of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses were finally on the rise to reach 23 tons after two years of decline. Overall, exports, however, continue to indicate a abrupt slump.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded remarkably to $228K in 2022. In general, exports, however, recorded a abrupt shrinkage.
| Export of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Iran (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Azerbaijan | 69.3 | 245 | 161 | 102 | 13.8% |
| Tunisia | 54.8 | N/A | 44.0 | 71.8 | 9.4% |
| Tajikistan | N/A | N/A | N/A | 38.5 | 0% |
| Armenia | 34.7 | N/A | N/A | N/A | 0% |
| Jordan | 94.3 | N/A | N/A | N/A | 0% |
| Italy | 23.4 | N/A | N/A | N/A | 0% |
| Others | 23.4 | 4.2 | 1.7 | 15.9 | -12.1% |
| Total | 300 | 249 | 207 | 228 | -8.7% |
Top Export Markets for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses from Iran in 2022:
- Tajikistan (12.8 tons)
- Azerbaijan (4.6 tons)
- Tunisia (3.3 tons)
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Iran. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Iran
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Iran
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
268
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Iran.
255
This report provides an in-depth analysis of the medicaments containing hormones market in Iran.
334
This report provides an in-depth analysis of the medicaments containing insulin market in Iran.
237
This report provides an in-depth analysis of the medicaments containing penicillin market in Iran.
220
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Iran.
213
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Iran.
317
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
496
This report provides an in-depth analysis of the global medicaments containing hormones market.
490
This report provides an in-depth analysis of the global medicaments containing insulin market.
595
This report provides an in-depth analysis of the global medicaments containing penicillin market.
124
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
124
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
